OOIR: Observatory of International Research

Papers

(The median citation count of International Clinical Psychopharmacology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	40
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	32
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	24
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	20
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	19
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	18
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis	16
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	16
Managing depression in the elderly: real-world clinical considerations and perspectives	15
Clinical specificity profile for novel rapid acting antidepressant drugs	15
Open issues in bipolar and antipsychotic treatments	15
Preliminary evidence that blood extracellular nicotinamide phosphoribosyltransferase increases with antidepressant response to chronotherapeutics and to monoaminergic drugs	14
Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.)	14
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	14
Antipsychotic polypharmacy in Japanese outpatients with schizophrenia: prevalence and sex- and age-related patterns	13
Assessing treatment adherence in psychiatry: a comparison of clinical judgment and therapeutic drug monitoring in acute care	13
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	12
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	12
Debated issues in major psychoses	12
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	11
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	11
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	11
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	10
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	10
Modulating factors in mood disorders treatment	10

Transcranial direct current stimulation and cognitive modifiability in obsessive compulsive disorder: a reaction to recent findings by Pellegrini et al.	10
Addressing the challenge of treatment adherence in major depressive disorder in different settings	10
Suicide behind bars: time to tackle barriers to mental healthcare access in prisons	10
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	10
The Gordian knot of the immune-redox systems’ interactions in psychosis	10
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	10
Elevated liver transaminases among patients with psychiatric disorders	10
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	9
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	9
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	9
Innovation in psychopharmacology	9
Differentiating aspects of oral and long-acting injectable antipsychotic drugs for tailoring the therapy of schizophrenia in clinical practice: a narrative review	9
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	8
Interplay of environmental and clinical factors in psychiatric disorders	8
Effectiveness and safety of long-acting aripiprazole 960 mg: preliminary findings from a prospective real-world observational study	8
Manic episode in a patient with pancreatic adenocarcinoma: a case report	8
Case report and systematic review of cerebellar vermis alterations in psychosis	8
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	8
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	7
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	7
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	7
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences	7
Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy	7
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	7
The challenge of managing difficult to treat psychiatric conditions	7
Innovative pharmacotherapy for mood disorders: safety, cardiometabolic burden, and real-world implementation	7
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	7
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	7
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	6
Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation	6
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence	6
Unspoken needs: an essential perspective in the treatment of schizophrenia	6
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features	6
Association between the number of delirium-associated medications and postoperative delirium in older adults: a multicenter retrospective study	6
The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial	6
From cognitive endpoints to clinical reality in schizophrenia: antipsychotic choice, adherence, and functional outcomes	6
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?	6
Efficacy and safety of adjunctive therapy with lumateperone in major depressive disorder: a randomized-, double-blind, placebo-controlled clinical trial	5
In search of clinical targets for suicide prevention in major depressive disorder	5
Aripiprazole: examining the clinical implications of D2 affinity	5
An investigation into the association between suicide mortality rate and lithium levels in potable water: a review study	5
Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis	5
An algorithmic approach to the case management of patients diagnosed with schizophrenia and substance use disorders: what is the evidence?	4
Frequency, risk factors, and impacts on quality of life of the restless legs syndrome and side effects among antidepressant users in a tertiary hospital: an observational cross-sectional study	4
Agranulocytosis after long-term clozapine use: a case report	4
Crocus sativus (saffron) adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled trial	4
Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study	4
Evaluating the influence of nonproblematic alcohol intake on the outcome of major depression	4
Brexpiprazole augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary retrospective observational study	4
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder	4

Catatonic postpartum paternal depression as a first debut of a bipolar disorder: a case report	4
Diabetes mellitus in patients with chronic bipolar disorder: prevalence, clinical correlates and relationship with homocysteine	4
The effect of early or late initiation of long-acting antipsychotics on the caregiver burden in schizophrenia	4
Lurasidone in first-episode psychosis with predominant depressive symptoms: a case report	4
Associations of adolescent psychosocial factors to later benzodiazepine use: a population-based follow-up study of adolescent psychiatric inpatients in Northern Finland	4
The effects of lurasidone on five symptom domains and individual items in schizophrenia: Post-hoc analysis from Phase 3 study	4
Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis	3
Can bupropion treat COVID-19–induced brain fog? A case series	3
Same outcome, different walls: rethinking comparisons in prison suicide research	3
Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder	3
Rhabdomyolysis during adjunctive treatment with cariprazine in a clozapine-resistant schizophrenia patient	3
An observational study on the effects of as-needed use of various antipsychotic drugs for agitation due to psychotic disorders	3
l-carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial	3
More must be done to reduce cardiovascular risk for patients on antipsychotic medications	3
Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report	3
Beyond symptom reduction: targeting cognitive deficits in obsessive-compulsive disorder treatment	3
Antidepressant treatment in complex clinical pictures	3
Severe methodological problems in a recent review and analysis of the association between lithium concentration in potable water and suicide rates	3
Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis	3
Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial	3
DRESS syndrome: quetiapine associated case report and literature review	3
Pharmacologic treatment of depression in Alzheimer’s disease	3
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry	3
Dissociative episode and panic attacks triggered by pitolisant in a narcoleptic patient	3
Resistance to antidepressant treatment among patients with major depressive disorder: a nationwide study	3
Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort	3
Characteristics and outcomes of cases with methylphenidate abuse, dependence or withdrawal: an analysis of spontaneous reports in EudraVigilance	3
Comparing adherence and persistence of common selective serotonin reuptake inhibitors in veterans with major depressive disorder: a retrospective analysis of Veterans Affairs healthcare data	3
Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis	3
Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations	3
Investigating the psychological effects of home quarantine during the early peaks of the COVID-19 pandemic: a survey from Iran	3
Raising awareness for adult ADHD diagnosis: addressing diagnostic challenges, comorbidities, and the path to proper recognition	3
Risperidone as an adjuvant treatment for obsessive-compulsive symptoms in patients with bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial	3